1. Home
  2. RBB vs GOSS Comparison

RBB vs GOSS Comparison

Compare RBB & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBB
  • GOSS
  • Stock Information
  • Founded
  • RBB 2008
  • GOSS 2015
  • Country
  • RBB United States
  • GOSS United States
  • Employees
  • RBB N/A
  • GOSS N/A
  • Industry
  • RBB Major Banks
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • RBB Finance
  • GOSS Health Care
  • Exchange
  • RBB Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • RBB 288.8M
  • GOSS 262.5M
  • IPO Year
  • RBB 2017
  • GOSS 2019
  • Fundamental
  • Price
  • RBB $18.50
  • GOSS $1.38
  • Analyst Decision
  • RBB Hold
  • GOSS Strong Buy
  • Analyst Count
  • RBB 4
  • GOSS 3
  • Target Price
  • RBB $21.25
  • GOSS $7.33
  • AVG Volume (30 Days)
  • RBB 73.8K
  • GOSS 2.5M
  • Earning Date
  • RBB 07-21-2025
  • GOSS 08-11-2025
  • Dividend Yield
  • RBB 3.45%
  • GOSS N/A
  • EPS Growth
  • RBB N/A
  • GOSS N/A
  • EPS
  • RBB 1.17
  • GOSS N/A
  • Revenue
  • RBB $98,305,000.00
  • GOSS $124,590,000.00
  • Revenue This Year
  • RBB $15.58
  • GOSS N/A
  • Revenue Next Year
  • RBB $8.35
  • GOSS $91.14
  • P/E Ratio
  • RBB $15.86
  • GOSS N/A
  • Revenue Growth
  • RBB N/A
  • GOSS N/A
  • 52 Week Low
  • RBB $14.40
  • GOSS $0.66
  • 52 Week High
  • RBB $25.30
  • GOSS $1.55
  • Technical
  • Relative Strength Index (RSI)
  • RBB 63.50
  • GOSS 61.04
  • Support Level
  • RBB $18.12
  • GOSS $1.20
  • Resistance Level
  • RBB $18.94
  • GOSS $1.39
  • Average True Range (ATR)
  • RBB 0.49
  • GOSS 0.09
  • MACD
  • RBB 0.14
  • GOSS 0.00
  • Stochastic Oscillator
  • RBB 82.68
  • GOSS 82.91

About RBB RBB Bancorp

RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: